Mild Behavioral Impairment an Early Indicator of Alzheimer’s

Based in Atlanta, Eugene E. Houchins III is the founder and president of the American Life Fund Corp, a company that offers pathways to funds for people with life-threatening conditions. Eugene E. Houchins III is particularly interested in cancer research and Alzheimer’s disease research.

According to recent research conducted at the McGill University Research Centre for Studies in Aging, a correlation exists between mild behavioral impairment (MBI) and Alzheimer’s disease. The noncognitive symptoms of MBI typically occur among individuals who are still cognitively healthy.

The study found that MBI is strongly associated with amyloid plaques in the brain, which is an initial pathological change associated with the early stages of Alzheimer’s. These specific proteins are associated with abnormal human behavior such as MBI, which can subsequently manifest as memory loss.

By using an MBI checklist, physicians may be able to identify people who are at a higher risk of dementia even before symptoms begin to manifest. The result will be treatment at earlier stages of Alzheimer’s progression, which may have a greater chance of slowing or reversing the disease.